Dermatology
Chronic spontaneous urticaria – the impact on patient quality of life, ongoing developments in treatments and the importance of greater awareness
October 3, 2025Medical Communications, Research and Development Dermatology, Immunology, acute urticaria, chronic spontaneous urticaria, dermatology, immunology
The current forms of immunotherapy, how T cell therapy works and what the future holds
UCB announces first-in-patient trial success for galvokimig in atopic dermatitis
September 18, 2025Medical Communications, Research and Development Dermatology, UCB, atopic dermatitis, clinical trial
UCB has reported positive early clinical trial results for galvokimig, an investigational therapy for adults with moderate-to-severe atopic dermatitis (AD). …
Boehringer Ingelheim and LEO Pharma partner to develop treatment for generalised pustular psoriasis
July 21, 2025Medical Communications, Mergers and Acquisitions, Research and Development Boehringer Ingelheim, Dermatology, LEO Pharma, Spevigo, generalised pustular psoriasis, partnership, skin disease
Boehringer Ingelheim and LEO Pharma have partnered to commercialise and further develop Spevigo (spesolimab), a treatment for generalised pustular psoriasis …
Five facts about UV exposure and sun safety
July 7, 2025Medical Communications Dermatology, Five Facts, Oncology, Skin, melanoma, skincare
1We can acclimatise to UV exposure. For example, we’re more likely to burn if there’s a sunny spell earlier in …
LEO Pharma appoints Helle Hedegaard Juhl as EVP of global people & corporate affairs
July 7, 2025Manufacturing and Production Dermatology, Helle Hedegaard Juhl, LEO Pharma, Skin, dermatology
Danish dermatology company, LEO Pharma, announced the appointment of new executive vice president (EVP) of global people and corporate affairs, …
Mallia strengthens its advisory board as it accelerates hair loss treatment
July 7, 2025Manufacturing and Production Dermatology, Skin, biopharma, dermatology, hair loss, mallia
German dermatology company, Mallia Innovations, has appointed Jens Holstein, Alexandra Ogilvie and Ulrich Dauer to its advisory board, strengthening its …
Galderma launches clinical trials for nemolizumab in systemic sclerosis and chronic pruritus of unknown origin
June 27, 2025Research and Development Dermatology, Galderma, chronic pruritus of unknown origin, clinical trials, dermatological conditions, dermatology, nemolizumab, systemic sclerosis
Galderma has announced the launch of two phase 2 clinical trials evaluating its monoclonal antibody, nemolizumab, in two conditions: systemic …
NICE recommends spevigo for rare and severe psoriasis flares
June 20, 2025Medical Communications, Research and Development Dermatology, NHS, National Institute for Health and Care Excellence, generalised pustular psoriasis
The National Institute for Health and Care Excellence (NICE) has recommended Spevigo (spesolimab) for the treatment of generalised pustular psoriasis …
Dupixent improves symptoms in patients with skin of colour, study shows
June 11, 2025Advocacy Development, Medical Education, Research and Development Dermatology, Dupixent, Regeneron, Sanofi, atopic dermatitis, dermatology, underserved populations
Sanofi and Regeneron have announced results from the collaborative phase 4 DISCOVER study, presented at the Revolutionizing Atopic Dermatitis Conference, …
LEO Pharma initiates phase 2a trial of delgocitinib cream for rare skin condition
June 3, 2025Research and Development Dermatology, LEO Pharma, Skin, clinical trial, delgocitinib cream, rare skin condition
LEO Pharma has initiated a phase 2a trial investigating delgocitinib cream in adults with mild-to-severe palmoplantar pustulosis (PPP). The DELTA …
DEBRA Research and Dermaliq Therapeutics collaborate to advance treatment for rare skin disorder
May 29, 2025Research and Development DEBRA Research, Dermaliq Therapeutics, Dermatology, epidermolysis bullosa, non-profit organisation, skin disorders
Global non-profit organisation, DEBRA Research, and clinical dermatology company, Dermaliq Therapeutics, have announced a collaboration to advance drug development for …
UK Researcher Wins Prestigious IBSA Foundation Fellowship for Pioneering Dermatology Study
May 28, 2025Medical Communications, Research and Development Dermatology, IBSA Foundation Fellowship, Institut Biochimique SA (IBSA), Masami Ando Kuri, Milan Italy, Wellcome Sanger Institute, dermatology
Masami Ando Kuri from the Wellcome Sanger Institute named one of six global winners of the 2024 IBSA Foundation Fellowships. …
Boehringer Ingelheim’s Spevigo gains additional approvals in US and China
March 20, 2024Medical Communications Boehringer Ingelheim, Dermatology, FDA, Spevigo, psoriasis
Boehringer Ingelheim has announced that Spevigo (spesolimab-sbzo) has been approved by the US Food and Drug Administration (FDA) for the …
Sanofi shares phase 2b results for dermatitis treatment
March 12, 2024Research and Development Dermatology, Sanofi, amlitelimab, atopic dermatitis, clinical trial, dermatitis
Sanofi has shared positive results from part 2 of the investigational phase 2b STREAM-AD study of amlitelimab for adult patients …
Almirall licenses Novo Nordisk’s anti-IL-21 monoclonal antibody for dermatology treatment
February 23, 2024Research and Development Almirall, Dermatology, Novo Nordisk, dermatology, monoclonal antibody
Almirall has announced that it has entered into an exclusive license agreement with Novo Nordisk for the rights to its …
Latest content
